Flavocure Biotech Inc.
Flavocure Pancreatic Drug Discovery Attracts Major Asian Equity Investor
Baltimore, Maryland--(Newsfile Corp. - April 9, 2019) - Dr. Henry Lowe, the executive Chairman of Flavocure Biotech Inc, today announced that Denning Growth Fund ("DGF") has invested $1.5 million USD in Flavocure Biotech, Inc. a disruptive innovator in oncological drug discovery. DGF, which is controlled by one of Asia's ...2019-04-09 12:19 PM ET
Flavocure Biotech, Inc. Announces Special Appointments to the Advisory Board and Regulatory Affairs
Baltimore, Maryland--(Newsfile Corp. - February 25, 2019) - Dr. Henry Lowe Ph.D. announces - It is with pleasure that Flavocure Biotech, Inc. welcomes the creation of Advisory Board Chairman, reporting to the company's board of directors. In the creation of this new role, Dr. Jose Luis Calderon, M.D. has ...2019-02-25 11:00 AM ET
Flavocure Announces Initiation of IND Enabling Studies for Drug to Treat Pancreatic and Glioblastoma Cancers
Baltimore, Maryland--(Newsfile Corp. - January 16, 2019) - Flavocure Biotech, Inc., announced today that it has initiated Investigational New Drug (IND) enabling studies for its cannabis derived drug, FBL-03G. The studies, which are estimated to cost over $1 million, have been independently sponsored by the company's Executive Vice Chairman, ...2019-01-16 10:00 AM ET